28933 Introduction to chemical modification of protein therapeutics

2024/2025

Part of NNF funded AIM-Bio education program
Kursusinformation
Introduction to chemical modification of protein therapeutics
Engelsk
2,5
Ph.d., Fagligt fokuseret kursus
Kurset udbydes som enkeltfag
Fixed contact times will be 15-16 May 2023, as agreed with AIM-Bio leadership
Campus Lyngby
2 days direct contact time, plus preparation and report writing (2 weeks) - Lectures, workshop and written exercise
[Kurset følger ikke DTUs normale skemastruktur]
Submitted report two weeks after the end of the course
Afløsningsopgave
Written report
Report over two weeks following the course
bestået/ikke bestået , intern bedømmelse
N/A og N/A
N/A
N/A
N/A , N/A
N/A , N/A
John Woodley , Lyngby Campus, Bygning 227 , jw@kt.dtu.dk
28 Institut for Kemiteknik
BTEC, NC State University, USA, supplying some of the material as agreed
www.kt.dtu.dk
Hos underviser

With jw@kt.dtu.dk
Overordnede kursusmål
This course aims to cover an introduction to the chemical modification of therapeutic proteins. This is an advanced technique of great importance to the future production of therapeutic proteins, therefore the modification of these proteins will be placed in the context of the current biopharmaceutical industry.
Læringsmål
En studerende, der fuldt ud har opfyldt kursets mål, vil kunne:
  • Describe chemical modification techniques relevant to protein therapeutics and their benefits, including acylation, PEGylation, and antibody-drug conjugation.
  • Understand appropriate procedures to perform basic protein modifications, including reactor types and operation.
  • List reaction parameters that must be controlled for successful modification.
  • Describe the purification steps following modification required to remove residual reaction components and isolate the target, including process chromatography.
  • Understand the approaches to analysis, such that modifications can be carefully controlled.
  • Understand the potential of new methods of chemical modification, such as enzymatic methods.
  • Understand opportunities for new medicines based on these technologies
  • Understand remaining limitations in new chemical-modification procedures
Kursusindhold
1. Introduction to chemical modification of therapeutic proteins in the context of drug development, including the benefits of such modifications. Techniques will include acylation, PEGylation and antibody-drug conjugation.
2. Processes for the production of chemically modified proteins, including reactor selection. Background chemistry to include sufhydryl and amino group chemistry.
3. Downstream processing, including impurity removal and product isolation, also via process chromatography (hydrophobic interaction, size exclusion and ion exchange) .
4. Analytical methods to assess reactor and downstream performance, and ensure adequate control, also via on-line monitoring (SDS-PAGE, MALDI-TOF and HPLC).
5. Workshop to explore enzymatic methods for chemical modification of therapeutic proteins, especially antibody-drug conjugation.
6. Report to evaluate new enzymatic methods for chemical modification of therapeutic proteins.
Litteraturhenvisninger
A variety of research articles. Some examples are given beneath:
• Walsh, G. 2018. Biopharmaceutical benchmarks 2018. Nature Biotechnol 36(12), 1136-1145.
• Gong, H.H., Ihle, N., Jones, M.T., Kelly, L., Raglione. T., Whitlock, S., Zhang, Q., Zheng, J. 2018. Control strategy for small molecule impurities in antibody-drug conjugates. AAPS PharmSciTech 19(3), 971-977.
• Hutchinson, M.H., Hendricks, R.S., Lin, X.X, Olson, D.A. 2018. Chapter 40 – process development and manufacturing of antibody-drug conjugates. Elsevier, pp. 813
Bemærkninger
N/A
Sidst opdateret
02. maj, 2024